Infectious Diseases
News from the FDA/CDC
2019-2020 flu season starts off full throttle
Five states and Puerto Rico already are at the highest level of flu activity, the CDC reports.
Article
FDA approves cefiderocol for multidrug-resistant, complicated urinary tract infections
The approval is for patients with limited or no alternative treatment options and includes a warning of Fetroja’s higher all-cause mortality rate...
From the Journals
Fewer bloodstream infections with FMT for C. difficile
Fecal microbiota transplantation for C. difficile infection is associated with fewer bloodstream infections and lower mortality than...
From the Journals
Measles causes B-cell changes, leading to ‘immune amnesia’
This leads to an increase of secondary infections after a bout of measles.
From the Journals
A sepsis death linked to fecal microbiota transplantation
Two patients developed bacteremia after receiving a fecal microbiota transplant from the same donor whose stool contained extended-spectrum beta-...
Conference Coverage
Flu vaccine cuts infection severity in kids and adults
Recent U.S. data compiled by the CDC documented that children and adults who received influenza vaccines had fewer severe infections.
From the Journals
New test edges closer to rapid, accurate ID of active TB
The blood-based triage test, which relies upon four host proteins and one TB antigen, is another step closer toward standards proposed by the WHO...
Opinion
Flu vaccine: Larger impact on influenza burden than you thought?
Even the current modestly effective flu vaccines have significant benefit, protecting U.S. populations from serious disease and death.
News from the FDA/CDC
New York declares end to 2018 measles outbreak
Reports of unrelated measles cases in the state continue.
Conference Coverage
IDWeek examined hot topics in the clinical treatment of infectious diseases
WASHINGTON –
News from the FDA/CDC
Measles cases continue to decline
Only two new cases were reported during the week ending Sept. 5.